TARS logo
Tarsus Pharmaceuticals, Inc.(TARS)
Last print unknown agoAbout this dataData status
$69.50▲1.43 (2.10%)Stale · unknown oldEarnings · Nov 3

TARS Operating Expenses

$597.84MTTM · USD

Period ending:

TARS FY Operating ExpensesUSD
TARS FY Operating Expenses2018-12-31: $1.35M2019-12-31: $4.22M2020-12-31: $26.74M2021-12-31: $67.11M2022-12-31: $87.57M2023-12-31: $159.01M2024-12-31: $290.70M2025-12-31: $491.65M$491.65M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TARS operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Tarsus Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
491,645,000
290,696,000
159,012,000
87,573,000
67,109,000
26,737,000
4,224,000
1,349,000

Compare operating expenses

All TARS financial metrics · TARS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.